Is use of exogenous estrogen associated wih temporomandibular signs and symptoms?

BACKGROUND: Studies of historical data suggest a link between exogenous estrogen use and referral for treatment for temporomandibular disorders, or TMDs. The purpose of the authors' study was to determine the association between exogenous estrogen use and signs and symptoms of TMD assessed by direct...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of the American Dental Association (JADA) Vol. 132; no. 3; pp. 319 - 331
Autores principales: Hatch JP, Rugh JD, Sakai S, Saunders MJ
Formato: CEU exam questions research tables/charts Journal Article
Publicado: American Dental Association Mar2001
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107048733&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 107048733
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00028177
        DEN
      jtl: Journal of the American Dental Association (JADA)
      issn: 00028177
      maglogo: N
    pubinfo:
      dt: Mar2001
      vid: 132
      iid: 3
      pid: 8266
      pub: American Dental Association
      place: Chicago, Illinois
    artinfo:
      ui:
        107048733
        107048733
        2001077787
        NLM11258088
        107048733
      ppf: 319
      ppct: 12
      formats:
      tig:
        atl: Is use of exogenous estrogen associated wih temporomandibular signs and symptoms?
      aug:
        au:
          Hatch JP
          Rugh JD
          Sakai S
          Saunders MJ
        affil: Professor, Departments of Psychiatry and Orthodontics, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229-3900; hatch@uthscsa.edu
      sug:
        subj:
          Hormone Replacement Therapy Adverse Effects
          Temporomandibular Joint Diseases Etiology
          Adult
          Middle Age
          Aged
          Aged, 80 and Over
          Female
          Texas
          Stratified Random Sample
          Fisher's Exact Test
          Chi Square Test
          Spearman's Rank Correlation Coefficient
          Mann-Whitney U Test
          T-Tests
          Multiple Logistic Regression
          Null Hypothesis
          Sensitivity and Specificity
          Male
          Descriptive Statistics
          Premenopause
          Postmenopause
          Risk Factors
          Education, Continuing (Credit)
          Funding Source
          Human
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Aged, 80 & over
          Female
          Male
      ab: BACKGROUND: Studies of historical data suggest a link between exogenous estrogen use and referral for treatment for temporomandibular disorders, or TMDs. The purpose of the authors' study was to determine the association between exogenous estrogen use and signs and symptoms of TMD assessed by direct physical examination in a randomly selected community sample of primarily postmenopausal women. METHODS: A calibrated clinical examiner examined a stratified random sample of 510 women aged 37 to 82 years using the Craniomandibular Index, or CMI. All medications that subjects were taking at the time of the examination were identified by interview and examination of subjects' medication containers on two occasions. One hundred seventy-four subjects were taking medications containing estrogen, and 336 were taking no such medications. RESULTS: The muscle and joint signs and symptoms of women taking and not taking estrogen were not significantly different after the authors controlled for sociocultural, demographic and health care utilization variables. Estrogen use also failed to distinguish women receiving relatively high and low scores on the CMI. CONCLUSION: Estrogen replacement therapy does not place women at increased risk of developing TMDs. CLINICAL IMPLICATIONS: Clinicians need not be concerned that patients taking oral contraceptives or replacement estrogens are at increased risk of developing TMDs.
      pubtype: Academic Journal
      doctype:
        CEU
        exam questions
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N